7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(ADP-ribose) polymerase inhibitors

Details for Australian Patent Application No. 2004295057 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Van Dun, Jacobus Alphonsus Josephus; Wouters, Walter Boudewijn Leopold; Mabire, Dominique JeanPierre; Guillemont, Jerome Emile Georges; Somers, Maria Victorina Francisca

Agent Shelston IP

Pub. Number AU-B-2004295057

PCT Pub. Number WO2005/054209

Priority 03078650.3 20.11.03 EP

Filing date 18 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 25 November 2010

International Classifications

C07D 241/44 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/054209 Priority application(s): WO2005/054209

25 November 2010 Application Accepted

  Published as AU-B-2004295057

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295058-6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors

2004295056-Method for producing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives